IE
DSGN icon

Israel Englander’s Design Therapeutics DSGN Stock Holding History

Israel Englander’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14M Buy
147,714
+38,786
+36% +$484K ﹤0.01% 3764
2026
Q1 		$1.16M Sell
108,928
-71,938
-40% -$728K ﹤0.01% 4287
2025
Q4 		$1.7M Buy
180,866
+112,043
+163% +$877K ﹤0.01% 4085
2025
Q3 		$518K Buy
+68,823
New +$345K ﹤0.01% 5044
2025
Q2 		– Sell
-87,988
Closed -$340K – 5955
2025
Q1 		$340K Buy
+87,988
New +$420K ﹤0.01% 5027
2024
Q4 		– Sell
-207,257
Closed -$1.12M – 6051
2024
Q3 		$1.12M Sell
207,257
-403,546
-66% -$1.9M ﹤0.01% 4179
2024
Q2 		$2.05M Buy
610,803
+126,335
+26% +$492K ﹤0.01% 3524
2024
Q1 		$1.95M Buy
484,468
+64,405
+15% +$172K ﹤0.01% 3761
2023
Q4 		$1.11M Sell
420,063
-409,417
-49% -$938K ﹤0.01% 4067
2023
Q3 		$1.96M Buy
829,480
+549,601
+196% +$2.56M ﹤0.01% 3569
2023
Q2 		$1.76M Sell
279,879
-510,334
-65% -$3.12M ﹤0.01% 3595
2023
Q1 		$4.56M Buy
790,213
+273,402
+53% +$2.04M ﹤0.01% 2693
2022
Q4 		$5.3M Buy
516,811
+375,313
+265% +$5.09M ﹤0.01% 2760
2022
Q3 		$2.37M Buy
+141,498
New +$2.82M ﹤0.01% 3600
2021
Q4 		– Sell
-14,169
Closed -$208K – 6920
2021
Q3 		$208K Buy
+14,169
New +$236K ﹤0.01% 6089
2021
Q2 		– Sell
-253,037
Closed -$7.57M – 6628
2021
Q1 		$7.57M Buy
+253,037
New +$8.53M 0.01% 2099

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Israel Englander's DSGN Position: Q2 2026 in Review

Israel Englander increased its Design Therapeutics (DSGN) stake by 36% in Q2 2026, buying an estimated $484K and bringing the position to 147,714 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #3764.

Israel Englander first reported a position in DSGN in Q1 2021 and has held it in 16 quarters since. The position peaked at $7.57M in Q1 2021. 136 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • Israel Englander held 147,714 shares of Design Therapeutics worth $2.14M as of Q2 2026.
  • Israel Englander bought 38,786 Design Therapeutics shares in Q2 2026, an estimated $484K.
  • Design Therapeutics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3764 holding.
  • Israel Englander first reported a position in Design Therapeutics in Q1 2021 and has held it in 16 quarters since.
  • Israel Englander's Design Therapeutics position peaked at $7.57M in Q1 2021.
  • 136 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.